Presenting Patient-generated Data in axSpA Care
Evaluating and Co-designing a Secondary Care Clinical Dashboard for Presenting Patient-generated Health Data in Axial Spondyloarthritis (axSpA) Care.
1 other identifier
observational
17
1 country
1
Brief Summary
Chronic health conditions are often managed in secondary care services that are facing long waiting lists, limited appointment times, and financial pressures. With the increasing availability of mobile devices including smartphones and wearables, patients can collect vast amounts of patient-generated health data (PGHD) outside of the clinic. This includes symptoms, biometrics and treatment adherence, providing clinicians with a more complete picture of patients' health. This data has the potential to support more insightful patient-clinician collaboration based on lived experiences; to enable remote clinical review; and ultimately, to improve the efficiency and quality of care. Clinicians and patients have expressed significant interest in using PGHD to manage their health, yet most attempts to review this data in clinic are unsuccessful. This project will investigate this problem with a case study in axial spondyloarthritis (axSpA) care. Firstly, a model will be created of how the axSpA care pathway works, including activities, data, and outcomes. Following this a newly implemented PGHD platform for axSpA care at the Royal United Hospitals (RUH) Bath will be evaluated. This evaluation will take place at the RUH, and will involve consultation observations and follow-up interviews with patients and clinicians. It will also involve a series of co-design workshops with patients and clinicians to explore their views on how the current platform may be optimised and improved, including their views on the potential value of predictive analytics. This research will provide insights how the platform is used during consultations, the barriers surrounding its uptake and impact across all parts of the axSpA model, and users' requirements for future versions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2026
CompletedFirst Submitted
Initial submission to the registry
February 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
CompletedFirst Posted
Study publicly available on registry
August 24, 2026
CompletedAugust 24, 2026
August 1, 2025
6 months
February 18, 2026
August 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Quotes and resulting themes from semi-structured interviews and workshops with patients and clinicians relating to self-management and patient-generated health data
Thematic analysis of interviews and co-design workshops with patients and clinicians to identify themes relating to patient self-management and the use of patient-generated health data in the treatment and management of axSpA
From enrolment until end of interview or optional co-design workshop (up to 6 months)
Eligibility Criteria
Patients treated for axSpA at RUH
You may qualify if:
- Adults over 18 with a diagnosis of axSpA
- Treated at the Royal National Hospital for Rheumatic Diseases, at the Royal United Hospitals Bath NHS Foundation Trust
- Due to have a planned consultation during the study period
- If participating in the interview via Teams, access to an electronic device (computer, laptop, tablet, or smartphone) and email address is required. If participating over the phone or via Teams, a quiet, private space is required to conduct the interview.
You may not qualify if:
- \- The person believes that participation may cause them to feel distress, discomfort or embarrassment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal National Hospital for Rheumatic Diseases, at the Royal United Hospitals Bath NHS Foundation Trust
Bath, United Kingdom
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 18, 2026
First Posted
August 24, 2026
Study Start
February 10, 2026
Primary Completion
July 31, 2026
Study Completion
July 31, 2026
Last Updated
August 24, 2026
Record last verified: 2025-08